Rivian (RIVN) closed at $16.69 on July 28, 2026, following a bounce from the 200-day after the Piper Sandler upgrade to Overweight with a $20 target. The at 18.21 remains in neutral-cautious territory, while 10-year yields at 4.6% continue to pressure unprofitable growth names. The stock is holding above the 200-day ($15.74) but below the 20-day ($17.34), with histogram deeply negative and at 49, indicating weak near-term momentum. Q2 2026 earnings on July 30 are the defining catalyst, with consensus expecting -$0.78 and ~$1.58B revenue. Insider buying by CEO RJ Scaringe ($1.16M) and CFO Claire McDonough ($98K) signals management conviction. Estimate revisions for FY2026 have improved 12% over 90 days and Piper Sandler upgraded the stock. Fundamental progress includes first positive gross margin in Q1 2026 and raised 2026 delivery guidance. However, annual FCF burn of $1.3B, net debt of $403M, and short interest of 12.4% highlight continued risks. The long-term thesis depends on successful R2 scaling and reaching profitability by 2027. Near-term, the setup is cautious with earnings event risk, but insider buying and improving fundamentals argue for a BUY on dips with strict sizing.
Decision
Live price
$16.69
Recommendation score
68%
68%
Confidence
60%
60%
Outlook by horizon
1M
HOLD
Near
6M
BUY
Mid
1Y
BUY
Long
Primary catalyst
The Q2 2026 earnings report on July 30 will be the single most market-moving catalyst, providing R2 delivery data, margin updates, and cash burn guidance. Consensus expects -$0.78 and ~$1.58B revenue. Any surprise on deliveries or margin trajectory could trigger a 10%+ move.
Reduce to 50% of normal size due to high volatility ( 6.6% of price), imminent earnings event (1 day), and elevated at 18.21. Full position appropriate only if stabilizes below 16 and price holds above 200-day post-earnings.
Thesis Snapshot
Why It Works
The R2 launch is a transformative product that can scale volume from thousands to hundreds of thousands. Gross margin has already turned positive, and the raised delivery guidance signals strong demand. Insider buying shows management is confident in the outlook. The Piper Sandler upgrade validates improving fundamentals. If R2 demand meets expectations and macro conditions stabilize, the stock could double from current levels over 12 months as the path to profitability becomes clearer.
What Breaks It
The discounted capital raise signals financial strain and further dilution. Rivian is burning $1.3B in FCF annually, and the R2 ramp may not generate sufficient margin given intense competition from Tesla's Model Y L and legacy automakers. The Zacks Earnings ESP of -4.29% suggests a potential Q2 miss. Another capital raise or a liquidity crisis could push the stock below $10. Technical damage with a break below the 200-day would confirm near-term bearishness.
A weekly close below $14.50 would break the structural uptrend and confirm that the recovery from the June low has failed, invalidating the near-term bullish thesis.
FCF burn of $1.3B may require additional capital raise before profitability, further diluting shareholders and pressuring the stock.
R2 demand could disappoint as EV market slows, competition intensifies, and consumer sentiment shifts, especially given the J.D. Power quality ranking.
Rising interest rates (10Y at 4.6%) and above 18 compress valuations and increase risk-off sentiment, making the stock vulnerable to multiple compression and sell-offs.
Upcoming earnings report on July 30 carries binary event risk; a miss could lead to a 10-15% decline.
Watch Next
Next earnings: Jul 30, 2026
The Q2 2026 earnings report on July 30 will be the single most market-moving catalyst, providing R2 delivery data, margin updates, and cash burn guidance. Consensus expects -$0.78 and ~$1.58B revenue. Any surprise on deliveries or margin trajectory could trigger a 10%+ move.
Signal Dashboard
Decision inputs
6 signals
Fundamental
12.9%
Upside to analyst mean target
RIVN trades at of 4.37x, well above the auto industry average of 0.6x and even its own peer average of 0.7x, reflecting a premium for expected growth. However, forward remains deeply negative at -9.14, and of -6.99x highlights persistent operating losses. The stock is priced for a successful turnaround, but the recent discounted capital raise at $15.50 diluted per-share value. The mean analyst target of $18.85 implies 13% upside from $16.69, but the $13-$25 range reflects high uncertainty and split opinions.
Technical
Neutral
Trend quality
Price ($16.69) is below ($17.34) and near ($16.52) but above ($15.74). The remains above the , keeping the golden cross intact since early July. However, the stock is in a short-term downtrend from the July 6 high of $20.20, and the recent bounce on July 28 failed to reclaim the 20-day , indicating weak near-term momentum. The price is testing the 200-day as key support.
Earnings
1d
Accelerating
Q1 2026 of -$0.33 beat consensus -$0.72 by 53.9%, driven by cost improvements and initial R2 launch momentum, marking the first positive gross margin quarter in company history.
News
Mixed-Bullish
Headline tone
The Q2 2026 earnings report on July 30 will be the single most market-moving catalyst, providing R2 delivery data, margin updates, and cash burn guidance. Consensus expects -$0.78 and ~$1.58B revenue. Any surprise on deliveries or margin trajectory could trigger a 10%+ move.
Macro
Neutral
4.60% 10Y / 18.2 VIX
With at 18.21 and 10-year yields at 4.6%, the macro backdrop is neutral-cautious; elevated yields still compress valuations for high-beta, pre-profit growth names like Rivian, making it sensitive to risk-off shifts. Near-term, stock-specific catalysts dominate.
Stability
High-Beta Growth
Satellite Upside
RIVN remains pre-profit with high cash burn but the R2 launch and first positive gross margin mark a key inflection point. Realized volatility near 90% and beta of 1.6 make it extremely sensitive to macro and sentiment. Strong insider buying provides management confidence, but near-term earnings event adds binary risk. Suited only as a high-risk satellite position with strict sizing.
Analyst Spread
Mean Target
$0.00
High / Low
$0 / $0
Median Target
$0.00
Consensus range
$13 - $25
— analysts
Mean
$13$19$25
Consensus
The mean target of $18.85 suggests 13% upside from $16.69. The wide range ($13-$25) and split consensus (12 buy/strong buy, 9 hold, 5 sell/strong sell) based on recommendation summary reflect the binary nature of the turnaround. Recent target raises and the Piper upgrade show improving sentiment, but holds and sells indicate continued uncertainty about profitability timing.
Positioning Pulse
Insider Signal
Strong Buy
Net Bias
Buy-heavy
Insider Own.
0.0%
Institutional Own.
0.0%
Interpretation
Concentrated insider buying by the CEO and CFO at current levels signals strong management confidence that the stock is undervalued post-capital raise and reflects confidence in the R2 launch and path to profitability.
Notable activity
CEO RJ Scaringe purchased 71,429 shares ($975K) and an additional 71,429 shares ($188K) in open-market buys in mid-July 2026, totaling ~$1.16M. CFO Claire McDonough bought 8,097 shares ($98K) on July 9. All are discretionary open-market buys, not 10b5-1 plans. The buying represents significant conviction relative to their salaries.
Market Context
Industry
Auto Manufacturers
Mixed-Bullish
Sentiment
27
Tracked names
4
Grouping
industry
Auto Manufacturers industry is currently Mixed-Bullish with an average recommendation score near 56. capital and conviction are improving across the group, and leadership is concentrated in TSLA, F, NIO.
Rotation Drivers
Average recommendation deltas are trending higher across Auto Manufacturers industry, which suggests improving risk appetite inside the group.
2 names are rated bullish versus 1 bearish names, keeping the group tone mixed-bullish.
Leadership is concentrated in TSLA, F, NIO, so those names are the cleanest read on group-level capital rotation.
The R2 launch expands Rivian's addressable market into the $50k-60k SUV segment, a key growth area. The Piper Sandler upgrade specifically cited improved demand outlook and smooth R2 ramp. The theme is strengthening as R2 deliveries began in June, but competition from Tesla and legacy automakers, along with macro headwinds, temper enthusiasm.
Piper Sandler upgrade on July 28 highlighted improved demand outlook and smooth R2 ramp as key catalysts.
Piper Sandler upgrade specifically cites 'improved demand outlook' for EVs.
Rivian's autonomous driving roadmap includes a partnership with Uber for robotaxis with planned supervised point-to-point driving later in 2026. This theme could open high-margin software revenue streams if execution succeeds, but the timeline is uncertain and capital-intensive. Recent news does not update this development, making the outlook neutral near-term.
No new catalysts; the theme remains in background while near-term focus is on R2 scaling and earnings.
Uber's commitment to purchase R2s for robotaxi use.
The race toward autonomous driving continues, but no near-term milestones for Rivian.
Key Stats
23 metrics total
Market Cap
$24.16B
P/E (TTM)
0.0
Forward P/E
0.0
Revenue Growth
0.0%
ROE
0.0%
Beta
0.00
Full Metric Set
17 additional stats
Valuation Stack
Multiples and cash-flow framing.
Price / Sales
0.0
Price / Book
0.0
EV / EBITDA
0.0
Quality & Balance Sheet
Margins, leverage, and liquidity.
Gross Margin
0.0%
Operating Margin
0.0%
Debt / Equity
0.0
Current Ratio
0.00x
Quick Ratio
0.00x
Positioning & Range
Short interest and 52-week location.
Short % Float
0.0%
Short Ratio
0.00x
52W High
$0.00
52W Low
$0.00
From 52W High
-26.4%
From 52W Low
44.3%
Company Classification
Sector and industry context.
Sector
Consumer Cyclical
Industry
Auto Manufacturers
Additional Signals
Free Cash Flow
$0.00
Detailed Analysis
Valuation
RIVN trades at of 4.37x, well above the auto industry average of 0.6x and even its own peer average of 0.7x, reflecting a premium for expected growth. However, forward remains deeply negative at -9.14, and of -6.99x highlights persistent operating losses. The stock is priced for a successful turnaround, but the recent discounted capital raise at $15.50 diluted per-share value. The mean analyst target of $18.85 implies 13% upside from $16.69, but the $13-$25 range reflects high uncertainty and split opinions.
Balance Sheet
Rivian holds $4.83B cash against $5.23B total debt, resulting in net debt of $403M. Debt-to-equity of 118% is moderate. Negative operating and free cash flow indicate high annual cash burn, though the current ratio of 2.10x and quick ratio of 1.54x provide adequate near-term liquidity. The recent $1.16B capital raise was necessary to fund operations through profitability.
Growth
Revenue grew 11.4% YoY, with positive gross margin achieved for the first time in Q1 2026, a key inflection point. Operating margin remains deeply negative at -63.79%. The R2 rollout is expected to drive volume and margin expansion, with consensus FY2026 revenue forecast of $7.16B (+33% YoY from trailing). estimates for FY2026 have improved from -$2.95 to -$2.57 over 90 days, reflecting optimism on cost improvements. The growth trajectory is moderate but requires substantial capital.
Business Quality
Gross margin of 1.03% is very thin, while operating margin of -63.79% and margin of -54.87% indicate structural inefficiencies. of -65.69% and of -16.02% reflect heavy losses from high capital intensity. Current ratio of 2.10x and quick ratio of 1.54x provide adequate liquidity. Insider ownership at 33.21% aligns management with shareholders. The business quality is poor but improving from a low base.
Capital Allocation
Rivian is in heavy investment mode, spending on R2 tooling, assembly plant expansion, and autonomous driving R&D. Free cash flow of -$1.30B represents a negative FCF yield of -5.39%, indicating significant cash burn. The recent $1.16B discounted capital raise at $15.50 diluted shares but provides liquidity through 2027. No buybacks or dividends are expected; capital allocation is focused on growth and survival.
Estimate Revisions
estimates for FY2026 have improved by 12% over the last 90 days, with further improvement over the last 7 days (-2.605 to -2.567). For Q2 2026, estimates have been stable but slightly improved over 7 days. Recent analyst actions include an upgrade from Piper Sandler (Neutral to Overweight, target raised to $20) and target raises from Morgan Stanley ($12 to $13), UBS ($16 to $17), BNP Paribas ($22 to $24), indicating improving sentiment. However, the Zacks Earnings ESP of -4.29% suggests a potential miss.